Parallel Bio Raises $4.3M in Seed Funding
- ParallelBio, a Cambridge, MA-based biotech company, raised $4.3M in Seed funding
- The round was led by Refactor Capital, with participation from Y Combinator Jeff Dean, Breakout Ventures
- The company intends to use the funds to accelerate drug discovery
- ParallelBio has developed a platform that replicates the human immune system in a dish for drug discovery and development
- ParallelBio validated its ability to reproducibly model immune systems across a diverse patient background
